Clinical trial
NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection
NCT00315432 · Ortho Biotech Products, L.P., Industry · Completed
Key facts
| NCT number | NCT00315432 |
|---|---|
| Title | NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection |
| Official title | )A Study to Evaluate the Erythropoietic Response in HCV/HIV Co-Infected Patients Receiving Combination Ribavirin/Interferon Therapy |
| Lead sponsor | Ortho Biotech Products, L.P., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C, HIV, Anemia |
| Intervention type | Drug |
| Interventions | Pegylated Interferon and Ribavirin |
| Enrollment | 91 |
| Start date | Sep 1, 2000 |
| Completion | Nov 1, 2003 |
| First posted | Apr 18, 2006 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: